Oncology
Oncology
Advertisement
Rob DillardBreast Cancer | April 15, 2024
Soft tumor environments can cause triple-negative breast cancer to spread more aggressively.
Read More
Darwin KwokOncology | April 15, 2024
Darwin Kwok discusses how he felt about winning the award and what he’s learned from past recipients.
Rob DillardHead and Neck Cancer | April 12, 2024
The use of a 3D variable flip angle mapping technique is effective in patients with head and neck cancer undergoing CRT.
Rob DillardGynecologic Cancer | April 10, 2024
A blood-based machine learning assay may be able to differentiate patients with ovarian cancer from healthy patients.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Patients with a history of venous thromboembolism were more likely to receive VTE prophylaxis.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Patients ≥70 years of age were more likely to have a reduction in their palbociclib dosage.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Rates of treatment-related hypersensitivity reactions were low in an academic community setting.
Rebecca AraujoHOPA Annual Conference 2024 | April 9, 2024
Same-day administration of pegfilgrastim was not linked to a greater incidence of grade ≥3 neutropenia.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Lenvatinib plus pembrolizumab led to a clinically relevant response in patients with baseline metastasis.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Higher average talazoparib concentrations were associated with an increased risk of severe anemia and thrombocytopenia.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Decreasing the at-home dose of dexamethasone before paclitaxel treatment may help reduce the incidence of infusion reactions.
Rebecca AraujoHOPA Annual Conference 2024 | April 8, 2024
Protected administrative time was ranked as the most important change to improve well-being.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
Ibrutinib dose reductions were associated with fewer recurrent cardiac adverse events in patients with B-cell malignancies.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
The REMEDY trial evaluated remote continuous temperature monitoring in patients receiving cytotoxic chemotherapy.
Rebecca AraujoHOPA Annual Conference 2024 | April 3, 2024
Cemiplimab plus chemotherapy as a first-line treatment for advanced NSCLC led to improved survival.
Dr. Samilia Obeng-GyasiBreast Cancer | April 1, 2024
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
Rob DillardOvarian Cancer | March 28, 2024
Ovarian cancer patients value personalized follow-up care and reassurance.
Rob DillardBreast Cancer | March 5, 2024
For women with BRCA1 sequence variations, MRI surveillance is linked to lower breast cancer mortality.
Rob DillardOncology | February 26, 2024
A study found a "substantial deficit" of undiagnosed cancer cases during the COVID-19 pandemic.
Rob DillardHeart Failure | February 12, 2024
Many cardio-oncology patients at increased risk for congestive heart failure from cancer therapy have OSA.
Advertisement
Advertisement
Advertisement
Latest News

April 18, 2024